poisar

Stocks · News reference

Wells Fargo Maintains Hold Rating and $5 Price Target for Zentalis Pharmaceuticals

Fiscal.ai

Wells Fargo analyst Yanan Zhu has maintained a Hold rating and a $5 price target on Zentalis Pharmaceuticals.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading